The effects of 10 mg Lu AA21004 and 30 mg mirtazapine on actual driving performance in healthy subjects

Trial Profile

The effects of 10 mg Lu AA21004 and 30 mg mirtazapine on actual driving performance in healthy subjects

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Feb 2013

At a glance

  • Drugs Mirtazapine; Vortioxetine
  • Indications Major depressive disorder
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Dec 2011 New trial record
    • 09 Nov 2011 Results were reported at the 11th International Forum on Mood and Anxiety Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top